New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
07:11 EDTBLRXBioLineRx's BL-8040 for stem cell mobilization receives Orphan Drug designation
BioLineRx has received notice from the FDA confirming an Orphan Drug Designation of BL-8040 as a treatment for stem cell mobilization, in addition to the Orphan Drug Designation previously granted to BL-8040 as a treatment for Acute Myeloid Leukemia. Orphan Drug Designation entitles the sponsor to a seven-year marketing exclusivity period, clinical protocol assistance with the FDA, as well as federal grants and tax credits.
News For BLRX From The Last 14 Days
Check below for free stories on BLRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2014
07:06 EDTBLRXBioLineRx doses first patient for BL-8040's second indication in Phase 1 trial
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use